Clinical Trial Update: Desensitization With Bortezomib Before a Living Kidney Donation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating desensitization with bortezomib prior to living kidney donation; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease
• Kidney Transplantation

Drugs mentioned

• Velcade (bortezomib) (bortezomib)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Patients Awaiting a Living Kidney Donation | Phase 4 | Status: UNKNOWN